Corbus Pharmaceuticals

Home » Corbus Pharmaceuticals

Secondary

Corbus Pharmaceuticals

Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases.

Symbol

CRBP

Last Closing Price
$7.40

Shares
4,000,000

Effective Date
October 24, 2017

Underwriters
Cantor Fitzgerald & Co.

To view the prospectus for Corbus Pharmaceuticals, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253